Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
he didn't get the 2nd dose on time, he just got it a couple days ago; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a adult male patient who received HBV (Engerix B) for prophylaxis. Previously administered products included Engerix B (The 1st vaccination was received in 18-Mar-2025,). In JUL-2025, the patient received the 2nd dose of Engerix B. In JUL-2025, an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too long (Verbatim: he didn't get the 2nd dose on time, he just got it a couple days ago). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-JUL-2025 Pharmacist reported that question was in regards Engerix-B,he/she had an adult patient, who had received primary vaccination. The 1st vaccination was received in 18-Mar-2025, he didn't get the 2nd dose on time, he just got it a couple days ago, which led to Drug dose administration interval too long. The reporter wants to be asked so, gone furthermore 4 months to get the 2nd dose and I'm curious about timing on the 3rd dose, should we still do it at 6 months from the 1st dose? or should we delay it? should he get a 4th dose? Just wondering if there was any data around how to provide the 3rd dose" The HCP didn't mention the 2nd dose vaccination date.